MASHINIi

Passage Bio, Inc..

PASG.US | Research and experimental development on natural sciences and engineering

Passage Bio, Inc. is a clinical-stage genetic medicines company focused on developing transformative therapies for rare central nervous system (CNS) disorders. The company's pipeline includes adeno-associated virus (AAV)-delivered gene therapies targeting diseases with limited or no approved treatme...Show More

Ethical Profile

Mixed.

Passage Bio, Inc. is dedicated to developing gene therapies for rare, severe central nervous system disorders, addressing critical unmet medical needs and significantly contributing to better health outcomes. However, the development of these therapies inherently relies on animal testing for preclinical safety and efficacy assessments, a practice critics often highlight as conflicting with animal welfare principles. The potential high cost of gene therapies also presents future considerations for equitable patient access.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Passage Bio, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Passage Bio, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No evidence available to assess Passage Bio, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No quantitative data or specific information regarding fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical clause coverage in supplier contracts, share of spend on high-risk materials, or supplier diversity spend was found in the provided articles.

1
All articles explicitly state the absence of such data relevant to ethical sourcing practices.
2

Honest & Fair Business

0

No evidence available to assess Passage Bio, Inc. on Honest & Fair Business.

Kind to Animals

0

No relevant information was found in the provided articles to assess Passage Bio, Inc. against the 'Kind to Animals' value.

1
The single provided article explicitly stated that its content was inaccessible.
2

No War, No Weapons

0

No evidence available to assess Passage Bio, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No evidence was found in the provided articles to assess Passage Bio, Inc. against any of the 'Planet-Friendly Business' KPIs. The articles primarily focus on financial results, operational updates, workforce reductions, and investor conference participation, without any mention of environmental performance, emissions, renewable energy, water usage, waste management, climate targets, or other related metrics.

1

Respect for Cultures & Communities

0

No evidence available to assess Passage Bio, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess Passage Bio, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

The provided articles do not contain any specific, concrete data points or information related to waste management, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education for Passage Bio, Inc.

Own Passage Bio, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.